NDSIB
VRTX icon

North Dakota State Investment Board’s Vertex Pharmaceuticals VRTX Stock Holding History

North Dakota State Investment Board’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.75M Buy
7,547
+97
+1% +$43K 0.15% 98
2026
Q1 		$3.33M Sell
7,450
-1,371
-16% -$639K 0.14% 101
2025
Q4 		$4M Buy
+8,821
New +$3.8M 0.15% 101

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

North Dakota State Investment Board's VRTX Position: Q2 2026 in Review

North Dakota State Investment Board increased its Vertex Pharmaceuticals (VRTX) stake by 1.3% in Q2 2026, buying an estimated $43K and bringing the position to 7,547 shares worth $3.75M. The position accounts for 0.15% of the portfolio, ranked #98.

North Dakota State Investment Board first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $4M in Q4 2025. 1,751 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • North Dakota State Investment Board held 7,547 shares of Vertex Pharmaceuticals worth $3.75M as of Q2 2026.
  • North Dakota State Investment Board bought 97 Vertex Pharmaceuticals shares in Q2 2026, an estimated $43K.
  • Vertex Pharmaceuticals made up 0.15% of North Dakota State Investment Board's portfolio in Q2 2026, its #98 holding.
  • North Dakota State Investment Board first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • North Dakota State Investment Board's Vertex Pharmaceuticals position peaked at $4M in Q4 2025.
  • 1,751 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.